Physician profile
Robert E Shapiro
NPI 1740270909
$1,892.40
in general payments reported to CMS, 2019-2025
13 companies · $361 in 2025
The $361 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.50 · 2021: $137 · 2022: $1,251 · 2024: $86.55 · 2025: $361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $448.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $447.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $778.70 | 2022 | |
| Intuitive Surgical, INC. | $449.19 | 2022 | |
| Abiomed | $318.05 | 2025 | |
| Cardiovascular Systems INC. | $117.10 | 2021 | |
| Boston Scientific Corporation | $66.76 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $33.11 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $26.19 | 2024 | Gemtesa |
| Edwards Lifesciences Corporation | $24.02 | 2024 | Sapien 3 Ultra Resilia |
| Novo Nordisk INC | $21.94 | 2024 | Wegovy |
| Blue Earth Diagnostics | $17.80 | 2025 | Posluma |
| Coloplast Corp | $15.80 | 2025 | |
| Atricure, INC. | $14.40 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $9.34 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Shapiro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.